Cathie Wood is the founder of the ARK Innovation ETF (ARKK). Her approach focuses on disruptive innovation, and identifying companies with the potential to transform industries. Her portfolio primarily contains stocks that are in the early stages of development, but are expected to become major players in their respective industries. Furthermore, Cathie Wood emphasizes a long-term investment horizon. This enables ARK to realize the full potential of disruptive technologies as they mature and become widely adopted.
In this article, we'll look at one such company, Intellia Therapeutics (NTLA). As the No. 9 holding in Wood's flagship fund, NTLA accounts for a 3.6% weight in the ARK Innovation ETF, indicating Wood's confidence in the company's long-term growth prospects. Wall Street is also very optimistic, rating the stock a "strong buy" and expecting it to skyrocket by over 200%.
